期刊文献+

Comparison between high-frequency irreversible electroporation and irreversible electroporation ablation of small swine liver:follow-up of DCE-MRI and pathological observations 被引量:2

原文传递
导出
摘要 Background:High-frequency irreversible electroporation(H-FIRE)is a novel,next-generation nanoknife technology with the advantage of relieving irreversible electroporation(IRE)-induced muscle contractions.However,the difference between IRE and H-FIRE with distinct ablation parameters was not clearly defined.This study aimed to compare the efficacy of the two treatments in vivo.Methods:Ten Bamaminiature swinewere divided into two group:five in the 1-day group and five in the 7-day group.The efficacy of IRE and H-FIRE ablation was compared by volume transfer constant(Krans),rate constant(Kep)and extravascular extracellular volume fraction(Ve)value of dynamic contrast-enhanced magnetic resonance imaging(DCE-MRI),size of the ablation zone,and histologic analysis.Each animal underwent the IRE andH-FIRE.Temperatures of the electrodesweremeasured during ablation.DCE-MRI images were obtained 1,4,and 7 days after ablation in the 7-day group.All animals in the two groups were euthanized 1 day or 7 days after ablation,and subsequently,IRE and H-FIRE treated liver tissues were collected for histological examination.Student’s t test or Mann-Whitney U test was applied for comparing any two groups.One-way analysis of variance(ANOVA)test and Welch’s ANOVA test followed byHolm-Sidak’smultiple comparisons test,one-wayANOVAwith repeatedmeasures followed by Bonferroni test,or Kruskal-Wallis H test followed by Dunn’s multiple comparison test was used for multiple group comparisons and post hoc analyses.Pearson correlation coefficient test was conducted to analyze the relationship between two variables.Results:Higher Ve was seen in IRE zone than in H-FIRE zone(0.14±0.02 vs.0.08±0.05,t=2.408,P=0.043)on day 4,but no significant difference was seen in Ktrans or Kep between IRE and H-FIRE zones at all time points(all P>0.05).For IRE zone,the greatest Ktrans was seen on day 7,which was significantly higher than that on day 1(P=0.033).The ablation zone size of H-FIRE was significantly larger than IRE 1 day(4.74±0.88 cm^(2)vs.3.20�
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2021年第17期2081-2090,共10页 中华医学杂志(英文版)
基金 This work was supported by a grant from the National Natural Science Foundation of China(No.81771944).
  • 相关文献

参考文献2

二级参考文献32

  • 1Choon Hua Thng,Tong San Koh,David J Collins,Dow Mu Koh.Perfusion magnetic resonance imaging of the liver[J].World Journal of Gastroenterology,2010,16(13):1598-1609. 被引量:15
  • 2European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].Journal of Hepatology.2012(4) 被引量:41
  • 3Tao Jiang,Avinash Kambadakone,Naveen M. Kulkarni,Andrew X. Zhu,Dushyant V. Sahani.Monitoring Response to Antiangiogenic Treatment and Predicting Outcomes in Advanced Hepatocellular Carcinoma Using Image Biomarkers, CT Perfusion, Tumor Density, and Tumor Size (RECIST)[J].Investigative Radiology.2012(1) 被引量:3
  • 4Chao-Yu Hsu,Ying-Chun Shen,Chih-Wei Yu,Chiun Hsu,Fu-Chang Hu,Chih-Hung Hsu,Bang-Bin Chen,Shwu-Yuan Wei,Ann-Lii Cheng,Tiffany Ting-Fang Shih.Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil[J].Journal of Hepatology.2011(4) 被引量:2
  • 5Michael Ingrisch,Steven Sourbron.Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer[J].Journal of Pharmacokinetics and Pharmacodynamics.2013(3) 被引量:1
  • 6Shin‐Lei Peng,Chih‐Feng Chen,Ho‐Ling Liu,Chun‐Chung Lui,Yu‐Jie Huang,Tsung‐Han Lee,Chiung‐Chih Chang,Fu‐Nien Wang.Analysis of parametric histogram from dynamic contrast‐enhanced MRI: application in evaluating brain tumor response to radiotherapy[J].NMR Biomed.2012(4) 被引量:1
  • 7Errol E. Stewart,Hongtao Sun,Xiaogang Chen,Peter H. Schafer,Yong Chen,Bertha M. Garcia,Ting-Yim Lee.Effect of an Angiogenesis Inhibitor on Hepatic Tumor Perfusion and the Implications for Adjuvant Cytotoxic Therapy[J].Radiology.2012(1) 被引量:1
  • 8Davide Ippolito,Cristina Capraro,Alessandra Casiraghi,Cristina Cestari,Sandro Sironi.Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging[J].European Radiology.2012(4) 被引量:1
  • 9Chiun Hsu,Tsai-Sheng Yang,Teh-Ia Huo,Ruey-Kuen Hsieh,Chih-Wei Yu,Wei-Shou Hwang,Tsai-Yuan Hsieh,Wen-Tsung Huang,Yee Chao,Robin Meng,Ann-Lii Cheng.Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study[J].Journal of Hepatology.2012(5) 被引量:1
  • 10M. Leach,B. Morgan,P. Tofts,D. Buckley,W. Huang,M. Horsfield,T. Chenevert,D. Collins,A. Jackson,D. Lomas,B. Whitcher,L. Clarke,R. Plummer,I. Judson,R. Jones,R. Alonzi,T. Brunner,D. Koh,P. Murphy,J. Waterton,G. Parker,M. Graves,T. Scheenen,T. Redpath,M. Orton,G. Karczmar,H. Huisman,J. Barentsz,A. Padhani.Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging[J].European Radiology.2012(7) 被引量:2

共引文献17

同被引文献37

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部